Spinal fusion demand to drive South Korea's bone grafts market growth

It held an 8% share of the Asia-Pacific market in 2025.

South Korea's bone grafts and substitutes market is forecast to expand at a compound annual growth rate of 4% through 2033, driven by higher spinal fusion procedure volumes.

GlobalData said rising orthopaedic disorder incidence and demand for advanced bone regeneration technologies are also contributing to the market’s growth.

In 2025, the country held an 8% share of the Asia-Pacific bone grafts and substitutes market.

GlobalData identifies three product categories as the primary demand engine—recombinant protein products, synthetic biomaterials, and regenerative platforms.

“Adoption of synthetic bone substitutes and biologic graft materials is accelerating as clinicians pursue better patient outcomes, streamlined workflows, and minimally invasive techniques,” the report added.

Prerna Gupta, Medical Devices Analyst at GlobalData, noted that broader availability of advanced bone graft substitutes — supported by clinical education and improved market access — is expected to gain traction.

Gupta cautioned that clinical adoption rates will vary by region due to differences in reimbursement structures, regulatory pathways, and local practice norms.

Despite strong underlying demand fundamentals, she said that those structural differences could temper the pace of commercialisation across markets.